Skip to main content
HCPCS J1920 · Level II · Part B drug

J1920: labetalol hydrochloride, HCPCS Level II J code

Compiled from CMS files by the QuickIntell RCM Editorial Team · Data effective · Method: reference methodology · Report a data correction

Data currency: ASP payment limits: October 2026 (effective October 1, 2026); NCCI MUE tables: 2026 Q4 (effective October 1, 2026); NCCI PTP edits: v323r0 (2026 Q4) (effective October 1, 2026); OPPS Addendum B: October 2026 (effective October 1, 2026); ASC Addendum BB (covered ancillary services): October 2026 (effective October 1, 2026). Next CMS release: January 1, 2027 (quarterly update).

Key facts for J1920

Billing unit
5 MG
Inj, labetalol hcl, 5mg
ASP payment limit
$0.588
October 2026; +169.7% vs July 2026
Practitioner MUE
none published
CMS publishes no MUE for this code
OPPS status
SI N
NCCI exposure
no PTP pairs
Coverage articles
0
none list this code

TL;DR

HCPCS J1920 is the Level II code for Injection, labetalol hydrochloride, 5 mg, billed per 5 MG. The Medicare Part B ASP payment limit for October 2026 is $0.588 per billing unit, up 169.7% from July 2026. Under OPPS it carries status indicator N. J1920 is billed in units of 5 MG; the quantity administered, the NDC package and the units on the claim must reconcile, which is the check that prevents CARC 16 and 151 returns on this line. Other HCPCS codes whose descriptor names labetalol hydrochloride: J1921 (the Hikma product (manufacturer named in its CMS descriptor); not therapeutically equivalent to J1920). The ASP crosswalk maps 23 NDCs to it, sold as Labetalol HCl by Hikma Pharmaceuticals USA Inc., Pfizer Inc, Sagent Pharmaceuticals. No current Billing and Coding Article lists J1920, so coverage follows the FDA label, compendia and any applicable NCD.

Medicare Part B payment limit (ASP)

CMS sets the Part B payment limit for J1920 at $0.588 per 5 MG for October 2026, derived from manufacturer average sales price plus 6%, compared with $0.218 in July 2026. Beneficiary coinsurance is 20%.

ASP payment limits for J1920
QuarterPayment limitPerCoinsurance
October 2026$0.5885 MG20%
July 2026$0.2185 MG—
Source: CMS Medicare Part B Drug Payment Limit File. Commercial and Medicaid payers set their own rates.

NDC to HCPCS billing-unit conversion

The October 2026 ASP crosswalk maps 23 NDCs from 11 labelers to J1920. Report the NDC in the claim's drug segment and bill the number of J1920 units that equals the quantity administered divided by 5 MG; the last column gives units per full package.

NDCs that crosswalk to J1920
NDCDrug nameLabelerPackage sizeBilling units / package
00143-9320-01Labetalol HClHikma Pharmaceuticals USA Inc.20 × 120
00143-9622-01Labetalol HClHikma Pharmaceuticals USA Inc.20 × 120
00143-9623-01Labetalol HClHikma Pharmaceuticals USA Inc.40 × 140
00409-0125-25Labetalol HClPfizer Inc20 × 25500
00409-2267-54Labetalol HClPfizer Inc40 × 140
00409-2339-34Labetalol HClPfizer Inc4 × 1040
25021-0317-20Labetalol HClSagent Pharmaceuticals20 × 120
25021-0317-40Labetalol HClSagent Pharmaceuticals40 × 140
36000-0320-10Labetalol HClBaxter Healthcare Corporation4 × 1040
36000-0322-02Labetalol HClBaxter Healthcare Corporation20 × 120
36000-0324-02Labetalol HClBaxter Healthcare Corporation40 × 140
51662-1228-01Labetalol HClHF Acquisition Co. LLC, DBA HealthFirst20 × 120
51662-1602-01Labetalol HClHF Acquisition Co. LLC, DBA HealthFirst20 × 120
51662-1602-09Labetalol HClHF Acquisition Co. LLC, DBA HealthFirst20 × 120
65145-0124-01Labetalol HClCaplin Steriles USA Inc.20 × 120
65145-0125-01Labetalol HClCaplin Steriles USA Inc.40 × 140
70121-2428-03Labetalol HClAmneal Pharmaceuticals, LLC4 × 2496
72266-0102-01Labetalol HClFosun Pharma USA Inc.20 × 120
72266-0103-01Labetalol HClFosun Pharma USA Inc.40 × 140
72266-0103-41Labetalol HClFosun Pharma USA Inc.40 × 140
72572-0350-01Labetalol HClCivica, Inc.20 × 120
72603-0146-01Labetalol HClNorthstar RxLLC20 × 120
83301-0059-01Labetalol HClMullan Pharmaceutical Inc.40 × 140

Medically Unlikely Edits (MUE)

CMS does not publish an MUE for J1920 in the 2026 Q4 tables. Some MUE values are confidential and applied without publication, so unit limits can still deny; document the dose and the units calculation on every claim.

MUE for J1920 in every setting opens the lookup with this code filled in, next to any other code on the same claim.

NCCI edits and add-on relationships

No active practitioner PTP pair lists J1920 as a column-1 or column-2 code in v323r0. Drug supply codes are rarely bundled; the administration codes billed with them are where PTP edits usually apply.

The counts above are exposure, not answers for a specific claim. Check J1920 against another code to see whether a given pair bundles, which code is paid and whether a modifier can separate them.

J1920 is neither an add-on code nor a designated primary code in the 2026 Q4 NCCI add-on edit file.

Medicare coverage articles

No current Billing and Coding Article lists J1920 in its HCPCS table. Coverage then follows the drug's FDA label, compendia and any National Coverage Determination; check the Medicare Coverage Database before administering off-label.

Hospital outpatient (OPPS) status

In the October 2026 OPPS Addendum B, J1920 carries status indicator N. Status N means payment is packaged into the associated procedure and no separate OPPS payment is made.

Ambulatory surgical center (ASC) payment

In the October 2026 ASC Addendum BB (covered ancillary services), J1920 carries payment indicator N1, which CMS defines as "Packaged service/item; no separate payment made". An N1 drug is packaged in the ASC: the facility receives no separate payment because the surgical procedure's rate already includes it.

Common denials for J1920 and how to prevent them

NDC missing, invalid or not matched to the HCPCS code

units billed exceed the MUE for the date of service

diagnosis not covered by the applicable coverage article or LCD

For teams evaluating QuickIntell software

Evaluate a coding workflow for J1920

Use the unit, NDC and edit questions in this reference to scope a QuickCode evaluation for qualified coder review, documentation clarification and the billing handoff. Confirm supported code sets, data inputs and reviewer responsibilities; the reference tables do not establish that a particular automated check or payer integration is available.

Optional software evaluation, not payer support or help with an individual claim. For coverage or payment decisions, use the official sources on this page. Do not include patient information in a demo booking or inquiry.

Frequently asked questions — HCPCS J1920

What does HCPCS code J1920 describe?

J1920 is defined by CMS as "Injection, labetalol hydrochloride, 5 mg". Each billing unit represents 5 MG, so the units reported on the claim must equal the dose administered divided by that unit.

Is J1920 a CPT code?

No. J1920 is a HCPCS Level II code, the letter-plus-four-digit set CMS maintains for drugs such as labetalol hydrochloride; CPT codes are five-character codes maintained by the AMA. On a Part B claim J1920 reports the drug itself in 5 mg units, and the administration is billed on its own line.

What is the Medicare reimbursement for J1920 in October 2026?

The ASP-based payment limit is $0.588 per 5 MG, with 20% beneficiary coinsurance. The July 2026 limit was $0.218. Commercial payers use their own fee schedules.

Which NDCs map to J1920?

The October 2026 ASP crosswalk lists 23 NDCs from 11 labelers: Labetalol HCl (Hikma Pharmaceuticals USA Inc.); Labetalol HCl (Pfizer Inc); Labetalol HCl (Sagent Pharmaceuticals); Labetalol HCl (Baxter Healthcare Corporation). For example NDC 00143-9320-01 (package size 20) equals 20 billing units of J1920.

Does J1920 have NCCI bundling edits?

No active practitioner PTP pairs list J1920 as a column-1 or column-2 code in the v323r0 release.

J1920 vs J1921: what is the difference?

Both are HCPCS Level II codes whose descriptor names labetalol hydrochloride. What sets J1921 apart: the Hikma product (manufacturer named in its CMS descriptor); not therapeutically equivalent to J1920. J1920 is billed per 5 mg, limit $0.588; J1921 is billed per 5 mg, limit $0.874. Report the code whose descriptor matches the product and setting in the record.

Sources

Every figure on this page is taken from the CMS publications below, as released by the Centers for Medicare & Medicaid Services. Projection built 2026-11-16. Verify against the primary file before billing or contracting decisions. The reference methodology explains how each figure is computed from these files.

Disclaimer

This page is an operational reference compiled from CMS publications: the Medicare Part B drug payment limit and NDC crosswalk files, NCCI MUE and add-on edit tables, aggregate PTP statistics, OPPS Addendum B, ASC Addendum BB and the Medicare Coverage Database. Payment limits and rates are Medicare national amounts; commercial and Medicaid payers differ. CPT codes are shown as numbers only; CPT descriptors are copyright AMA. Nothing here is legal, clinical or billing advice.

Found a figure that does not match the CMS file? Report a data correction with the CMS file and the value you expected; the request reaches the editorial team through the contact form.